Answers are grounded in this paper and cite their sources.
Novel biomimetic hyperbranched copolymers that synthesized by polymerization of zwitterionic monomer (CBB) on the surface of a hyperbranched poly(3‐ethyl‐3‐(hydroxymethyl)oxetane) (HBPO) core and used as a drug delivery carrier have been investigated by analysis of protein‐adsorption‐resistance, cytotoxicity and cell type‐specific targeting properties. The as‐synthesized biomimetic hyperbranched copolymers showed low toxicity, favorable protein resistant properties and were ultrastable in 100% fetal bovine serum. Folic acid and rodiamin‐B were conjugated to the surface of synthesized micelles to endow it with target drug delivery and fluorescence activity, respectively. Intracellular uptake and in vitro cytotoxicity of HBPO‐poly(carboxybetaine) micelles were investigated. Doxorubicin was used as a model drug for Hela cells during the experiment. All results show that the biomimetic hyperbranched copolymer is a candidate carrier for target drug delivery.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: